CONCERTS: dynamic connection of fragments as an approach to de novo ligand design
- PMID: 8648605
- DOI: 10.1021/jm950792l
CONCERTS: dynamic connection of fragments as an approach to de novo ligand design
Abstract
We have implemented and tested a new approach to de novo ligand design, CONCERTS (creation of novel compounds by evaluation of residues at target sites). In this method, each member of a user-defined set of fragments is allowed to move independently about a target active site during a molecular dynamics simulation. This allows the fragments to sample various low-energy orientations. When the geometry between proximal fragments is appropriate, bonds can be formed between the fragments. In this fashion, larger molecules can be built. The bonding arrangement can subsequently be changed-breaking bonds between chosen fragment pairs and forming them between other pairs-if the overall process creates lower energy molecules. We have tested this method with various mixes of fragments against the active sites of the FK506 binding protein (FKBP-12) and HIV-1 aspartyl protease. In several cases, CONCERTS suggests ligands which are in surprisingly good agreement with known inhibitors of these proteins.
Similar articles
-
An automated method for dynamic ligand design.Proteins. 1995 Dec;23(4):472-90. doi: 10.1002/prot.340230403. Proteins. 1995. PMID: 8749844
-
Exhaustive docking of molecular fragments with electrostatic solvation.Proteins. 1999 Oct 1;37(1):88-105. Proteins. 1999. PMID: 10451553
-
BREED: Generating novel inhibitors through hybridization of known ligands. Application to CDK2, p38, and HIV protease.J Med Chem. 2004 May 20;47(11):2768-75. doi: 10.1021/jm030543u. J Med Chem. 2004. PMID: 15139755
-
Recent advances in de novo design strategy for practical lead identification.Med Res Rev. 2003 Sep;23(5):606-32. doi: 10.1002/med.10046. Med Res Rev. 2003. PMID: 12789688 Review.
-
Automated docking of flexible ligands: applications of AutoDock.J Mol Recognit. 1996 Jan-Feb;9(1):1-5. doi: 10.1002/(sici)1099-1352(199601)9:1<1::aid-jmr241>3.0.co;2-6. J Mol Recognit. 1996. PMID: 8723313 Review.
Cited by
-
From laptop to benchtop to bedside: structure-based drug design on protein targets.Curr Pharm Des. 2012;18(9):1217-39. doi: 10.2174/138161212799436386. Curr Pharm Des. 2012. PMID: 22316152 Free PMC article. Review.
-
AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization.J Cheminform. 2020 Apr 17;12(1):25. doi: 10.1186/s13321-020-00429-4. J Cheminform. 2020. PMID: 33431021 Free PMC article.
-
Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach.J Comput Aided Mol Des. 2001 Jun;15(6):573-86. doi: 10.1023/a:1011145123635. J Comput Aided Mol Des. 2001. PMID: 11495228
-
Further development and validation of empirical scoring functions for structure-based binding affinity prediction.J Comput Aided Mol Des. 2002 Jan;16(1):11-26. doi: 10.1023/a:1016357811882. J Comput Aided Mol Des. 2002. PMID: 12197663
-
Structure-based ligand design for flexible proteins: application of new F-DycoBlock.J Comput Aided Mol Des. 2001 Nov;15(11):979-96. doi: 10.1023/a:1014817911249. J Comput Aided Mol Des. 2001. PMID: 11989626
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources